"Throughout my 15 years of experience within pharmacy automation and hospital medical equipment, I have closely followed the development of pharmaceutical robots. I personally witnessed CytoCare's operation in Tokyo during a recent visit to TOSHO, and I was very impressed by Health Robotics' patented technological achievements. We look forward to promoting and servicing CytoCare, i.v.STATION, and i.v.SOFT in Norway. All of us at Beckman Automation are very pleased that this exclusive partnership enables us to contribute to improved patient care through a much safer and efficient workflow in the IV room", stated Tom Beckman, CEO of Beckman Automation AS.
CytoCare is the first and only robotic system proven to work anywhere in the world for the safe and sterile preparation of Hazardous Intravenous Admixtures, including Chemotherapy, Monoclonal Antibody Therapy, and Gene Therapy. With 56 installations currently under contract in 17 countries, CytoCare has long proven its unmatched flexibility to adapt to diverse pharmacy workflows and proprietary IV consumables in 4 continents. While several companies attempted the development of Chemotherapy Robotics as far back as 22 years ago, Cytocare is still the only robot that has been able to break the entry-barrier into the Intravenous Chemotherapy Automation Sector.
"I relish at the prospects of working with Beckman Automation to rapidly
deploy our unique and world-leading technologies in Norway. Beckman
Automation is a knowledge-intensive company with more than 15 years of
experience within the pharmacy automation and hospital's medical equipment
sectors. Beckman Automation has built an outstanding reputation by deliver
|SOURCE Health Robotics|
Copyright©2010 PR Newswire.
All rights reserved